How often can ketorolac (NSAID) be administered, given the last dose was at 10 pm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ketorolac Dosing Schedule

Ketorolac should be administered every 6 hours for IV/IM dosing and every 4-6 hours for oral dosing, with the next dose after 10 PM being appropriate at 4 AM (IV/IM) or as early as 2 AM (oral). 1, 2

Dosing Recommendations by Route

IV/IM Administration

  • Adults (17-64 years): 30 mg IV/IM every 6 hours, maximum daily dose of 120 mg 1
  • Elderly (≥65 years), renally impaired, or <50 kg: 15 mg IV/IM every 6 hours, maximum daily dose of 60 mg 1

Oral Administration

  • Adults (17-64 years): Initial dose 20 mg PO once, then 10 mg PO every 4-6 hours as needed, maximum daily dose of 40 mg 1, 2
  • Elderly (≥65 years), renally impaired, or <50 kg: Initial dose 10 mg PO once, then 10 mg PO every 4-6 hours as needed, maximum daily dose of 40 mg 1, 2

Important Considerations

Duration Limitations

  • Combined duration of IV/IM and oral ketorolac must not exceed 5 days 1, 2
  • Oral formulation should not be given as an initial dose, but only as continuation therapy after IV/IM dosing 2

Safety Precautions

  • Use the lowest effective dose for the shortest duration possible 2
  • Do not shorten the dosing interval of 4-6 hours for oral administration 2
  • Prescribe as needed rather than on a scheduled basis 3

Ceiling Effect

  • Ketorolac has a ceiling analgesic effect - doses above recommended amounts do not provide additional pain relief but increase adverse effect risk 1
  • Studies show that lower doses (7.5 mg every 6 hours) can be as effective as higher doses for pain management 4

Special Populations

Children

  • Not FDA approved for oral formulation in children under 17 years 1
  • For postoperative pain in children ≥1 year: 0.5 mg/kg IV initially, followed by 1.0 mg/kg IV every 6 hours 1, 5

Contraindications

  • History of peptic ulcer disease, GI bleeding, advanced renal impairment, cerebrovascular bleeding, coagulation disorders, pregnancy, or concurrent use with aspirin or other NSAIDs 1

Monitoring

  • Monitor for GI upset, bleeding, renal function changes, edema, and cardiovascular effects 1
  • Consider as part of multimodal analgesia approach when appropriate 3

Remember that ketorolac is a potent NSAID with significant analgesic properties but should be used cautiously due to its potential for adverse effects, particularly with prolonged use beyond the recommended duration.

References

Guideline

Pain Management with Ketorolac

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.